BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/22/2021 10:31:45 AM | Browse: 467 | Download: 917
 |
Received |
|
2020-10-30 03:21 |
|
Peer-Review Started |
|
2020-10-30 03:22 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-11-30 19:41 |
|
Revised |
|
2020-12-22 00:55 |
|
Second Decision |
|
2021-03-22 05:56 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-03-22 16:14 |
|
Articles in Press |
|
2021-03-22 16:14 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-04-15 14:01 |
|
Publish the Manuscript Online |
|
2021-04-22 10:31 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Review |
| Article Title |
Stem cell therapy for heart failure: Medical breakthrough, or dead end?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mathieu Rheault-Henry, Ian White, Diya Grover and Rony Atoui |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Rony Atoui, FACS, MD, MSc, Surgeon, Division of Cardiac Surgery, Health Sciences North, 865 Regent Street, Suite 301, Sudbury P3E 3Y9, Ontario, Canada. rony.atoui@gmail.com |
| Key Words |
Stem cells; Heart failure; Myocardial infarction; Regeneration; Remodeling; Ethical issues |
| Core Tip |
Cellular based therapeutics have emerged as a promising potential option for the treatment of heart failure. To date, there have been numerous clinical trials evaluating safety, efficacy and feasibility of the use of adult and pluripotent stem cells in the treatment of chronic cardiomyopathy. Although clinical results have varied, important lessons have been learned about the optimal cell type, route of administration and the implementation of tissue engineering. |
| Publish Date |
2021-04-22 10:31 |
| Citation |
Rheault-Henry M, White I, Grover D, Atoui R. Stem cell therapy for heart failure: Medical breakthrough, or dead end? World J Stem Cells 2021; 13(4): 236-259 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i4/236.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i4.236 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
